株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

医薬品原薬 (API) の世界市場の分析

Analyzing the Global Market for Active Pharmaceutical Ingredients 2018

発行 Aruvian's R'search 商品コード 712888
出版日 ページ情報 英文 390 Pages
即納可能
価格
本日の銀行送金レート: 1USD=111.17円で換算しております。
Back to Top
医薬品原薬 (API) の世界市場の分析 Analyzing the Global Market for Active Pharmaceutical Ingredients 2018
出版日: 2018年10月01日 ページ情報: 英文 390 Pages
概要

当レポートでは、世界の活性医薬成分 (API) の市場について分析し、世界のAPI市場の基本構造や内訳、最新動向、市場収益額の動向見通し (過去10年間・今後13年間分)、主な市場影響要因、地域別・主要国市場の詳細動向、主要企業のプロファイルなどについて調査しております。

エグゼクティブ・サマリー

医薬品原薬 (API) の概略

世界のAPI (医薬品原薬) 市場

  • 業界の概略
  • 業界の市場収益額
  • 業界の内訳
    • バイオテクノロジーAPI市場
    • 合成API市場
  • 概略:HPAPI (高薬理活性原薬)

世界のAPI市場に対する影響

アジア太平洋地域のAPI市場

  • 市場の概略
  • 市場収益額の推移・予測
  • 市場の内訳
    • バイオテクノロジーAPI市場
    • 合成API市場
  • アジア太平洋地域におけるAPIの用途
  • 市場への影響要因

中国のAPI市場

  • 市場の概略
  • 市場収益額の推移・予測
  • 市場の内訳
    • バイオテクノロジーAPI市場
    • 合成API市場

インドのAPI市場

日本のAPI市場

韓国のAPI市場

欧州のAPI市場

フランスのAPI市場

ドイツのAPI市場

イタリアのAPI市場

スペインのAPI市場

英国のAPI市場

北米のAPI市場

カナダのAPI市場

米国のAPI市場

主な市場参入企業

  • Albemarle Corporation
  • Allergan Plc
  • BASF SE
  • Boehringer Ingelheim GmbH
  • Bristol Myers Squibb Company
  • Koninklijke DSM N.V.
  • Lonza Group AG
  • Lupin Limited
  • Novartis AG
  • Pfizer Inc
  • Sigma-Aldrich Corporation
  • Teva Pharmaceutical Industries Limited
  • Ampac Fine Chemicals LLC
  • Aptuit, Inc
  • Aurobindo Pharma
  • Biocon Limited
  • Cambrex Corporation
  • Cipla Limited
  • Dishman Pharmaceuticals & Chemicals Ltd.
  • Dr. Reddy's Laboratories Limited
  • Fabbrica Italiana Sintetici
  • Medtronic Plc
  • Mylan Inc
  • Novasep Holding
  • Ranbaxy Laboratories
  • Sun Pharmaceutical Industries Limited
  • WuXi AppTec, Inc

用語一覧

目次

The global market for active pharmaceutical ingredients (API) has been growing steadily in recent years. Though the economic recession of 2008-2009 affected the growth of the market, nevertheless, the market has bounced back with strong growth since then. However, the industry is today facing a record number of blockbuster drugs going off patent. This is having a major impact on the global API industry as revenues of the API markets are being affected as generic drugs have started to make their presence felt on the market.

The United States remains one of the biggest players in the market, followed closely by China and India. Synthetic pharmaceuticals also continue to dominate the API industry as biotech APIs move up slowly. Major companies such as Teva, Dr Reddy's and Boehringer Ingelheim continue to invest heavily in the API industry and remain the leading players in the global active pharmaceutical ingredient market.

Aruvian Research analyzes the global API industry in its research report Analyzing the Global Market for Active Pharmaceutical Ingredients 2018. The report begins with an introduction to active pharmaceutical ingredients (APIs). An analysis of the global market for APIs includes an industry overview, industry revenues, industry segmentation by the biotech API market and the Synthetic API market and a profile of the High Potency Active Pharmaceutical Ingredient (HPAPAI) Market. We also analyze some of the major impacts on the global API market such as the ongoing and few upcoming patent expiries of blockbuster drugs.

An analysis of the market for APIs in Asia Pacific is carried out through an industry overview, analysis of industry revenues and industry segmentation, the therapeutic applications of APIs in Asia Pacific and the impacts on the industry. Key markets analyzed in Asia Pacific include China, India, Japan and South Korea.

An analysis of the market for APIs in Europe is carried out through an industry overview, analysis of industry revenues and industry segmentation, the therapeutic applications of APIs in Europe and the impacts on the industry. Key markets analyzed in Europe include France, Germany, Italy, Spain and the United Kingdom.

An analysis of the market for APIs in North America is carried out through an industry overview, analysis of industry revenues and industry segmentation, the therapeutic applications of APIs in North America and the impacts on the industry. Key markets analyzed in North America include Canada and the United States.

An analysis of the major industry players such as Teva, Albemarle, Allergan, Boehringer, Cipla and others is carried out through an analysis of their business profile, major products & services, and a SWOT analysis. This in-depth report on the Global Market for Active Pharmaceutical Ingredients 2018 from Aruvian Research is a comprehensive profile of this industry.

Table of Contents

A. Executive Summary

B. Introduction to Active Pharmaceutical Ingredients

C. Global Market for Active Pharmaceutical Ingredients (APIs)

  • C.1. Industry Overview
  • C.2. Industry Revenues
  • C.3. Industry Segmentation
    • C.3.1. Biotech API Market
    • C.3.2. Synthetic API Market
  • C.4. Brief Profile: High Potency Active Pharmaceutical Ingredients (HPAPIs)

D. Impacts on the Global API Market

  • D.1. Impact of the Economic Recession
  • D.2. Impact of Patent Expiries & Growing Uptake of Biologics
  • D.3. Increased Price Competition & Price Cuts by Governments
  • D.4. Growing Number of Mergers & Acquisitions & Increased Global Coverage
  • D.5. Regulatory Framework

E. Market for Active Pharmaceutical Ingredients (APIs) in Asia Pacific

  • E.1. Industry Overview
  • E.2. Industry Revenues
  • E.3. Industry Segmentation
    • E.3.1. Biotech API Market
    • E.3.2. Synthetic API Market
  • E.4. Therapeutic Applications of API in Asia Pacific
  • E.5. Impacts on the Industry

F. Market for Active Pharmaceutical Ingredients (APIs) in China

  • F.1. Industry Overview
  • F.2. Industry Revenues
  • F.3. Industry Segmentation
    • F.3.1. Biotech API Market
    • F.3.2. Synthetic API Market

G. Market for Active Pharmaceutical Ingredients (APIs) in India

  • G.1. Industry Overview
  • G.2. Industry Revenues
  • G.3. Industry Segmentation
    • G.3.1. Biotech API Market
    • G.3.2. Synthetic API Market

H. Market for Active Pharmaceutical Ingredients (APIs) in Japan

  • H.1. Industry Overview
  • H.2. Industry Revenues
  • H.3. Industry Segmentation
    • H.3.1. Biotech API Market
    • H.3.2. Synthetic API Market

I. Market for Active Pharmaceutical Ingredients (APIs) in South Korea

  • I.1. Industry Overview
  • I.2. Industry Revenues
  • I.3. Industry Segmentation
    • I.3.1. Biotech API Market
    • I.3.2. Synthetic API Market

J. Market for Active Pharmaceutical Ingredients (APIs) in Europe

  • J.1. Industry Overview
  • J.2. Industry Revenues
  • J.3. Industry Segmentation
    • J.3.1. Biotech API Market
    • J.3.2. Synthetic API Market
  • J.4. Therapeutic Applications of API in Europe
  • J.5. Impacts on the Industry

K. Market for Active Pharmaceutical Ingredients (APIs) in France

  • K.1. Industry Overview
  • K.2. Industry Revenues
  • K.3. Industry Segmentation
    • K.3.1. Biotech API Market
    • K.3.2. Synthetic API Market

L. Market for Active Pharmaceutical Ingredients (APIs) in Germany

  • L.1. Industry Overview
  • L.2. Industry Revenues
  • L.3. Industry Segmentation
    • L.3.1. Biotech API Market
    • L.3.2. Synthetic API Market

M. Market for Active Pharmaceutical Ingredients (APIs) in Italy

  • M.1. Industry Overview
  • M.2. Industry Revenues
  • M.3. Industry Segmentation
    • M.3.1. Biotech API Market
    • M.3.2. Synthetic API Market

N. Market for Active Pharmaceutical Ingredients (APIs) in Spain

  • N.1. Industry Overview
  • N.2. Industry Revenues
  • N.3. Industry Segmentation
    • N.3.1. Biotech API Market
    • N.3.2. Synthetic API Market

O. Market for Active Pharmaceutical Ingredients (APIs) in United Kingdom

  • O.1. Industry Overview
  • O.2. Industry Revenues
  • O.3. Industry Segmentation
    • O.3.1. Biotech API Market
    • O.3.2. Synthetic API Market

P. Market for Active Pharmaceutical Ingredients (APIs) in North America

  • P.1. Industry Overview
  • P.2. Industry Revenues
  • P.3. Industry Segmentation
    • P.3.1. Biotech API Market
    • P.3.2. Synthetic API Market
  • P.4. Therapeutic Applications of API in North America
  • P.5. Impacts on the Industry

Q. Market for Active Pharmaceutical Ingredients (APIs) in Canada

  • Q.1. Industry Overview
  • Q.2. Industry Revenues
  • Q.3. Industry Segmentation
    • Q.3.1. Biotech API Market
    • Q.3.2. Synthetic API Market

R. Market for Active Pharmaceutical Ingredients (APIs) in the US

  • R.1. Industry Overview
  • R.2. Industry Revenues
  • R.3. Industry Segmentation
    • R.3.1. Biotech API Market
    • R.3.2. Synthetic API Market

S. Major Industry Players

  • S.1. Albemarle Corporation
    • S.1.1. Business Profile
    • S.1.2. Major Products & Services
    • S.1.3. SWOT Analysis
  • S.2. Allergan Plc
    • S.2.1. Business Profile
    • S.2.2. Major Products & Services
    • S.2.3. SWOT Analysis
  • S.3. BASF SE
    • S.3.1. Business Profile
    • S.3.2. Major Products & Services
    • S.3.3. SWOT Analysis
  • S.4. Boehringer Ingelheim GmbH
    • S.4.1. Business Profile
    • S.4.2. Major Products & Services
    • S.4.3. SWOT Analysis
  • S.5. Bristol Myers Squibb Company
    • S.5.1. Business Profile
    • S.5.2. Major Products & Services
    • S.5.3. SWOT Analysis
  • S.6. Koninklijke DSM N.V.
    • S.6.1. Business Profile
    • S.6.2. Major Products & Services
    • S.6.3. SWOT Analysis
  • S.7. Lonza Group AG
    • S.7.1. Business Profile
    • S.7.2. Major Products & Services
    • S.7.3. SWOT Analysis
  • S.8. Lupin Limited
    • S.8.1. Business Profile
    • S.8.2. Major Products & Services
    • S.8.3. SWOT Analysis
  • S.9. Novartis AG
    • S.9.1. Business Profile
    • S.9.2. Major Products & Services
    • S.9.3. SWOT Analysis
  • S.10. Pfizer Inc
    • S.10.1. Business Profile
    • S.10.2. Major Products & Services
    • S.10.3. SWOT Analysis
  • S.11. Sigma-Aldrich Corporation
    • S.11.1. Business Profile
    • S.11.2. Major Products & Services
    • S.11.3. SWOT Analysis
  • S.12. Teva Pharmaceutical Industries Limited
    • S.12.1. Business Profile
    • S.12.2. Major Products & Services

S.12.3SWOT Analysis

  • S.13. Ampac Fine Chemicals LLC
  • S.14. Aptuit, Inc
  • S.15. Aurobindo Pharma
  • S.16. Biocon Limited
  • S.17. Cambrex Corporation
  • S.18. Cipla Limited
  • S.19. Dishman Pharmaceuticals & Chemicals Ltd.
  • S.20. Dr. Reddy's Laboratories Limited
  • S.21. Fabbrica Italiana Sintetici
  • S.22. Medtronic Plc
  • S.23. Mylan Inc
  • S.24. Novasep Holding
  • S.25. Ranbaxy Laboratories
  • S.26. Sun Pharmaceutical Industries Limited
  • S.27. WuXi AppTec, Inc

T. Glossary of Terms

List of Figures

  • Figure 1: Revenues of the Global Active Pharmaceutical Ingredient (API) Market (in USD Million), 2008-2020
  • Figure 2: Global API Industry Segmentation by Revenues (%), 2017
  • Figure 3: Revenues of the Global Biotech API Market (in USD Million), 2008-2020
  • Figure 4: Share of the Global Biotech API Market by Regions (%), 2017
  • Figure 5: Share of Revenues of the Global Biotech API Market by Regions (%), 2008-2020
  • Figure 6: Share of the Global Biotech API Market by Application Sector (%), 2017
  • Figure 7: Revenues of the Global Biotech API Market by Application Sector (in USD Million), 2007-2020
  • Figure 8: Revenues of the Global Synthetic API Market (in USD Million), 2008-2020
  • Figure 9: Share of the Global Synthetic API Market by Regions (%), 2017
  • Figure 10: Share of Revenues of the Global Synthetic API Market by Regions (%), 2008-2020
  • Figure 11: Share of the Global Synthetic API Market by Application Sector (%), 2017
  • Figure 12: Revenues of the Global Synthetic API Market by Application Sector (in USD Million), 2008-2020
  • Figure 13: Revenues of the Active Pharmaceutical Ingredient (API) Market in Asia Pacific (in USD Million), 2008-2020
  • Figure 14: Asia Pacific API Industry Segmentation by Revenues (%), 2017
  • Figure 15: Revenues of the Biotech API Market in Asia Pacific (in USD Million), 2008-2020
  • Figure 16: Share of the Biotech API Market in Asia Pacific by Countries (%), 2017
  • Figure 17: Performance & Growth of the Biotech API Market in Asia Pacific (%), 2008-2020
  • Figure 18: Share of Revenues of the Biotech API Market in Asia Pacific by Countries (%), 2008-2020
  • Figure 19: Share of the Biotech API Market in Asia Pacific by Application Sector (%), 2017
  • Figure 20: Revenues of the Biotech API Market in Asia Pacific by Application Sector (in USD Million), 2008-2020
  • Figure 21: Revenues of the Synthetic API Market in Asia Pacific (in USD Million), 2008-2020
  • Figure 22: Share of the Synthetic API Market in Asia Pacific by Countries (%), 2017
  • Figure 23: Performance & Growth of the Synthetic API Market in Asia Pacific (%), 2008-2020
  • Figure 24: Share of Revenues by Countries in Asia Pacific Synthetic API Industry (%), 2008-2020
  • Figure 25: Share of the Synthetic API Market in Asia Pacific by Application Sector (%), 2017
  • Figure 26: Revenues of the Synthetic API Market in Asia Pacific by Application Sector (in USD Million), 2008-2020
  • Figure 27: Revenue Breakdown of the API Market in Asia Pacific by Therapeutic Applications (%), 2017 & 2020
  • Figure 28: Revenues of the Active Pharmaceutical Ingredient (API) Market in China (in USD Million), 2008-2020
  • Figure 29: China API Industry Segmentation by Revenues (%), 2008-2020
  • Figure 30: Revenues of the Biotech API Market in China by Application Sector (in USD Million), 2008-2020
  • Figure 31: Share of China Biotech API Market by Application Sector (%), 2008-2020
  • Figure 32: Revenues of the Synthetic API Market in China by Application Sector (in USD Million), 2008-2020
  • Figure 33: Share of the Synthetic API Market in China by Application Sector (%), 2008-2020
  • Figure 34: Revenues of the Active Pharmaceutical Ingredient (API) Market in India (in USD Million), 2008-2020
  • Figure 35: India API Industry Segmentation by Revenues (%), 2008-2020
  • Figure 36: Revenues of the Biotech API Market in India by Application Sector (in USD Million), 2008-2020
  • Figure 37: Share of the Biotech API Market in India by Application Sector (%), 2008-2020
  • Figure 38: Revenues of the Synthetic API Market in India by Application Sector (in USD Million), 2008-2020
  • Figure 39: Share of the Synthetic API Market in India by Application Sector (%), 2008-2020
  • Figure 40: Revenues of the API Market in Japan by Industry Segmentation (in USD Million), 2008-2020
  • Figure 41: Product Type & Revenue Share of the API Market in Japan (%), 2008-2020
  • Figure 42: Revenues of the Biotech API Market in Japan by Application Sector (in USD Million), 2008-2020
  • Figure 43: Share of the Biotech API Market in Japan by Application Sector (%), 2008-2020
  • Figure 44: Revenues of Japan Synthetic API Market by Application Sector (in USD Million), 2008-2020
  • Figure 45: Share of the Synthetic API Market in Japan by Application Sector (%), 2008-2020
  • Figure 46: Revenues of the Active Pharmaceutical Ingredient (API) Market in South Korea (in USD Million), 2008-2020
  • Figure 47: South Korea API Industry Segmentation by Revenues (%), 2008-2020
  • Figure 48: Revenues of the Biotech API Market in South Korea by Application Sector (in USD Million), 2008-2020
  • Figure 49: Share of the South Korea Biotech API Market by Application Sector (%), 2008-2020
  • Figure 50: Revenues of the Synthetic API Market in South Korea by Application Sector (in USD Million), 2008-2020
  • Figure 51: Share of the Synthetic API Market in South Korea by Application Sector (%), 2008-2020
  • Figure 52: Revenues of the Europe Active Pharmaceutical Ingredient (API) Market (in USD Million), 2008-2020
  • Figure 53: European API Industry Segmentation by Revenues (%), 2017
  • Figure 54: Revenues of the European Biotech API Market (in USD Million), 2008-2020
  • Figure 55: Share of the European Biotech API Market by Countries (%), 2017
  • Figure 56: Performance & Growth of the Biotech API Market in Europe (%), 2008-2020
  • Figure 57: Share of Revenues of the European Biotech API Market by Countries (%), 2008-2020
  • Figure 58: Share of the European Biotech API Market by Application Sector (%), 2017
  • Figure 59: Revenues of the European Biotech API Market by Application Sector (in USD Million), 2008-2020
  • Figure 60: Revenues of the European Synthetic API Market (in USD Million), 2008-2020
  • Figure 61: Share of the European Synthetic API Market by Countries (%), 2017
  • Figure 62: Performance & Growth of the Synthetic API Market in Europe (%), 2008-2020
  • Figure 63: Share of Revenues of the Europe Synthetic API Market by Countries (%), 2008-2020
  • Figure 64: Share of the European Synthetic API Market by Application Sector (%), 2017
  • Figure 65: Revenues of the European Synthetic API Market by Application Sector (in USD Million), 2008-2020
  • Figure 66: Revenue Breakdown of the API Market in Europe by Therapeutic Applications (%), 2017 & 2020
  • Figure 67: Revenues of the Active Pharmaceutical Ingredient (API) Market in France (in USD Million), 2008-2020
  • Figure 68: France API Industry Segmentation by Revenues (%), 2008-2020
  • Figure 69: Revenues of the Biotech API Market in France by Application Sector (in USD Million), 2008-2020
  • Figure 70: Share of the Biotech API Market in France by Application Sector (%), 2008-2020
  • Figure 71: Revenues of the Synthetic API Market in France by Application Sector (in USD Million), 2008-2020
  • Figure 72: Share of the Synthetic API Market in France by Application Sector (%), 2008-2020
  • Figure 73: Revenues of the Active Pharmaceutical Ingredient (API) Market in Germany (in USD Million), 2008-2020
  • Figure 74: Revenue Share of the API Market in Germany by Product Type (%), 2008-2020
  • Figure 75: Revenues of the Biotech API Market in Germany by Application Sector (in USD Million), 2008-2020
  • Figure 76: Share of the Biotech API Market in Germany by Application Sector (%), 2008-2020
  • Figure 77: Revenues of the Synthetic API Market in Germany by Application Sector (in USD Million), 2008-2020
  • Figure 78: Share of the Synthetic API Market in Germany by Application Sector (%), 2008-2020
  • Figure 79: Revenues of the Active Pharmaceutical Ingredient (API) Market in Italy (in USD Million), 2008-2020
  • Figure 80: Italy API Industry Segmentation by Revenues (%), 2008-2020
  • Figure 81: Revenues of the Biotech API Market in Italy by Application Sector (in USD Million), 2008-2020
  • Figure 82: Share of the Biotech API Market in Italy by Application Sector (%), 2008-2020
  • Figure 83: Revenues of the Synthetic API Market in Italy by Application Sector (in USD Million), 2008-2020
  • Figure 84: Share of the Synthetic API Market in Italy by Application Sector (%), 2008-2020
  • Figure 85: Revenues of the Active Pharmaceutical Ingredient (API) Market in Spain (in USD Million), 2008-2020
  • Figure 86: Spain API Industry Segmentation by Revenues (%), 2008-2020
  • Figure 87: Revenues of the Biotech API Market in Spain by Application Sector (in USD Million), 2008-2020
  • Figure 88: Share of the Biotech API Market in Spain by Application Sector (%), 2008-2020
  • Figure 89: Revenues of the Synthetic API Market in Spain by Application Sector (in USD Million), 2008-2020
  • Figure 90: Share of the Synthetic API Market in Spain by Application Sector (%), 2008-2020
  • Figure 91: Revenues of the Active Pharmaceutical Ingredient (API) Market in the UK (in USD Million), 2008-2020
  • Figure 92: UK API Industry Segmentation by Revenues (%), 2008-2020
  • Figure 93: Revenues of the Biotech API Market in UK by Application Sector (in USD Million), 2008-2020
  • Figure 94: Share of the Biotech API Market in UK by Application Sector (%), 2008-2020
  • Figure 95: Revenues of the Synthetic API Market in the UK by Application Sector (in USD Million), 2008-2020
  • Figure 96: Share of the Synthetic API Market in UK by Application Sector (%), 2008-2020
  • Figure 97: Revenues of the Active Pharmaceutical Ingredient (API) Market in North America (in USD Million), 2008-2020
  • Figure 98: Industry Segmentation of the Active Pharmaceutical Ingredients (API) Market in North America by Revenues (%), 2008-2020
  • Figure 99: Revenues of the Biotech API Market in North America (in USD Million), 2008-2020
  • Figure 100: Share of the Biotech API Market in North America by Countries (%), 2017
  • Figure 101: Performance & Growth of the Biotech API Market in North America (%), 2008-2020
  • Figure 102: Share of Revenues of the Biotech API Market in North America by Countries (%), 2008-2020
  • Figure 103: Share of the Biotech API Market in North America by Application Sector (%), 2017
  • Figure 104: Revenues of the Biotech API Market in North America by Application Sector (in USD Million), 2008-2020
  • Figure 105: Revenues of the Synthetic API Market in North America (in USD Million), 2008-2020
  • Figure 106: Share of the Synthetic API Market in North America by Countries (%), 2017
  • Figure 107: Performance & Growth of the Synthetic API Market in North America (%), 2008-2020
  • Figure 108: Share of Revenues by Countries in North America Synthetic API Industry (%), 2008-2020
  • Figure 109: Share of the Synthetic API Market in North America by Application Sector (%), 2017
  • Figure 110: Revenues of the Synthetic API Market in North America by Application Sector (in USD Million), 2008-2020
  • Figure 111: Revenue Breakdown of the API Market in North America by Therapeutic Applications (%), 2017 & 2020
  • Figure 112: Revenues of the API Market in Canada by Industry Segmentation (in USD Million), 2008-2020
  • Figure 113: Revenue Share of the API Market in Canada by Industry Segments (%), 2008-2020
  • Figure 114: Revenues of the Canada Biotech API Market by Application Sector (in USD Million), 2008-2020
  • Figure 115: Share of the Canada Biotech API Market by Application Sector (%), 2008-2020
  • Figure 116: Revenues of the Canada Synthetic API Market by Application Sector (in USD Million), 2008-2020
  • Figure 117: Share of the Canada Synthetic API Market by Application Sector (%), 2008-2020
  • Figure 118: Revenues of the API Market in the US by Industry Segmentation (in USD Million), 2008-2020
  • Figure 119: Revenue Share of the API Market in the US by Industry Segments (%), 2008-2020
  • Figure 120: Revenues of the US Biotech API Market by Application Sector (in USD Million), 2008-2020
  • Figure 121: Share of the US Biotech API Market by Application Sector (%), 2008-2020
  • Figure 122: Revenues of the US Synthetic API Market by Application Sector (in USD Million), 2008-2020
  • Figure 123: Share of the US Synthetic API Market by Application Sector (%), 2008-2020

List of Tables

  • Table 1: Revenues of the Global Active Pharmaceutical Ingredient (API) Market (in USD Million), 2008-2020
  • Table 2: Revenues of the Global Biotech API Market (in USD Million), 2008-2020
  • Table 3: Revenues of the Global Biotech API Market by Application Sector (in USD Million), 2008-2020
  • Table 4: Revenues of the Global Synthetic API Market (in USD Million), 2008-2020
  • Table 5: Revenues of the Global Synthetic API Market by Application Sector (in USD Million), 2008-2020
  • Table 6: Revenues of the Active Pharmaceutical Ingredient (API) Market in Asia Pacific (in USD Million), 2008-2020
  • Table 7: Revenues of the Biotech API Market in Asia Pacific (in USD Million), 2008-2020
  • Table 8: Revenues of the Biotech API Market in Asia Pacific by Application Sector (in USD Million), 2008-2020
  • Table 9: Revenues of the Synthetic API Market in Asia Pacific (in USD Million), 2008-2020
  • Table 10: Share of Revenues by Countries in Asia Pacific Synthetic API Industry (in USD Million), 2008-2020
  • Table 11: Revenues of the Synthetic API Market in Asia Pacific by Application Sector (in USD Million), 2008-2020
  • Table 12: Revenue Breakdown of the API Market in Asia Pacific by Therapeutic Applications (%), 2017 & 2020
  • Table 13: Revenues of the Active Pharmaceutical Ingredient (API) Market in China (in USD Million), 2008-2020
  • Table 14: Revenues of the Biotech API Market in China by Application Sector (in USD Million), 2008-2020
  • Table 15: Revenues of the Synthetic API Market in China by Application Sector (in USD Million), 2008-2020
  • Table 16: Revenues of the Active Pharmaceutical Ingredient (API) Market in India (in USD Million), 2008-2020
  • Table 17: Revenues of the Biotech API Market in India by Application Sector (in USD Million), 2008-2020
  • Table 18: Revenues of the Synthetic API Market in India by Application Sector (in USD Million), 2008-2020
  • Table 19: Revenues of the API Market in Japan by Industry Segmentation (in USD Million), 2008-2020
  • Table 20: Revenues of the Biotech API Market in Japan by Application Sector (in USD Million), 2008-2020
  • Table 21: Revenues of Japan Synthetic API Market by Application Sector (in USD Million), 2008-2020
  • Table 22: Revenues of the Active Pharmaceutical Ingredient (API) Market in South Korea (in USD Million), 2008-2020
  • Table 23: Revenues of the Biotech API Market in South Korea by Application Sector (in USD Million), 2008-2020
  • Table 24: Revenues of the Synthetic API Market in South Korea by Application Sector (in USD Million), 2008-2020
  • Table 25: Revenues of the Europe Active Pharmaceutical Ingredient (API) Market (in USD Million), 2008-2020
  • Table 26: Revenues of the European Biotech API Market (in USD Million), 2008-2020
  • Table 27: Revenues of the European Biotech API Market by Application Sector (in USD Million), 2008-2020
  • Table 28: Revenues of the European Synthetic API Market (in USD Million), 2008-2020
  • Table 29: Revenues of the European Synthetic API Market by Application Sector (in USD Million), 2008-2020
  • Table 30: Revenue Breakdown of the API Market in Europe by Therapeutic Applications (%), 2017 & 2020
  • Table 31: Pricing & Reimbursement Mechanism in Top Markets in Europe, 2017
  • Table 32: Revenues of the Active Pharmaceutical Ingredient (API) Market in France (in USD Million), 2008-2020
  • Table 33: Revenues of the Biotech API Market in France by Application Sector (in USD Million), 2008-2020
  • Table 34: Revenues of the Synthetic API Market in France by Application Sector (in USD Million), 2008-2020
  • Table 35: Revenues of the Active Pharmaceutical Ingredient (API) Market in Germany (in USD Million), 2008-2020
  • Table 36: Revenues of the Biotech API Market in Germany by Application Sector (in USD Million), 2008-2020
  • Table 37: Revenues of the Synthetic API Market in Germany by Application Sector (in USD Million), 2008-2020
  • Table 38: Revenues of the Active Pharmaceutical Ingredient (API) Market in Italy (in USD Million), 2008-2020
  • Table 39: Revenues of the Biotech API Market in Italy by Application Sector (in USD Million), 2008-2020
  • Table 40: Revenues of the Synthetic API Market in Italy by Application Sector (in USD Million), 2008-2020
  • Table 41: Revenues of the Active Pharmaceutical Ingredient (API) Market in Spain (in USD Million), 2008-2020
  • Table 42: Revenues of the Biotech API Market in Spain by Application Sector (in USD Million), 2008-2020
  • Table 43: Revenues of the Synthetic API Market in Spain by Application Sector (in USD Million), 2008-2020
  • Table 44: Revenues of the Active Pharmaceutical Ingredient (API) Market in the UK (in USD Million), 2008-2020
  • Table 45: Revenues of the Biotech API Market in UK by Application Sector (in USD Million), 2008-2020
  • Table 46: Revenues of the Synthetic API Market in the UK by Application Sector (in USD Million), 2008-2020
  • Table 47: Revenues of the Active Pharmaceutical Ingredient (API) Market in North America (in USD Million), 2008-2020
  • Table 48: Revenues of the Biotech API Market in North America (in USD Million), 2008-2020
  • Table 49: Revenues of the Biotech API Market in North America by Application Sector (in USD Million), 2008-2020
  • Table 50: Revenues of the Synthetic API Market in North America (in USD Million), 2008-2020
  • Table 51: Revenues of the Synthetic API Market in North America by Application Sector (in USD Million), 2008-2020
  • Table 52: Revenue Breakdown of the API Market in North America by Therapeutic Applications (%), 2017 & 2020
  • Table 53: Drugs with Patent Expiries till 2017
  • Table 54: Revenues of the API Market in Canada by Industry Segmentation (in USD Million), 2008-2020
  • Table 55: Revenues of the Canada Biotech API Market by Application Sector (in USD Million), 2008-2020
  • Table 56: Revenues of the Canada Synthetic API Market by Application Sector (in USD Million), 2008-2020
  • Table 57: Revenues of the API Market in the US by Industry Segmentation (in USD Million), 2008-2020
  • Table 58: Revenues of the US Biotech API Market by Application Sector (in USD Million), 2008-2020
  • Table 59: Revenues of the US Synthetic API Market by Application Sector (in USD Million), 2008-2020
Back to Top